Tenaya Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Tenaya Therapeutics has filed its 2026 proxy statement, seeking stockholder approval for director elections, auditor ratification, and an amendment to its 2021 Equity Incentive Plan.
NASDAQ
Tenaya Therapeutics will hold its annual stockholders meeting on May 28, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Tenaya Therapeutics will hold its annual stockholders meeting virtually on May 28, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Tenaya Therapeutics will hold its annual stockholders meeting on May 30, 2024, to elect directors and ratify the appointment of its independent auditor.
NASDAQ
Tenaya Therapeutics will hold its annual meeting of stockholders virtually on May 30, 2024, to elect directors and ratify the appointment of its independent accounting firm.